Azitra Inc Share Price
AZTRAzitra Inc Stock Performance
Open $0.21 | Prev. Close $0.21 | Circuit Range N/A |
Day Range $0.21 - $0.22 | Year Range $0.21 - $2.96 | Volume 7,211 |
Average Traded $0.21 |
Azitra Inc Share Price Chart
About Azitra Inc
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.
Azitra Inc Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $0.21 | $0.21 | -1.89% |
05-Feb-26 | $0.22 | $0.21 | -9.01% |
04-Feb-26 | $0.23 | $0.23 | +0.43% |
03-Feb-26 | $0.23 | $0.23 | -6.07% |
02-Feb-26 | $0.25 | $0.25 | +0.41% |
30-Jan-26 | $0.25 | $0.25 | -7.87% |
29-Jan-26 | $0.27 | $0.27 | -2.91% |